# Prescient Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prescient-surgical

- Industry: Medical Devices & Equipment
- Headquarters: San Carlos, US
- Website: www.prescientsurgical.com
- Total disclosed funding: $14M
- Latest round: Series B (Oct 26, 2018)
- Investors on record: 4

## About

Prescient Surgical, Inc. develops innovative surgical technologies aimed at enhancing patient safety and improving surgical outcomes. Their advanced solutions address critical challenges in the operating room.Prescient Surgical, Inc. was founded in 2012 and is based in San Carlos, US. The company specializes in creating surgical solutions designed to reduce infection rates. In October 2018, Prescient Surgical raised USD 7.62 mn in Series B funding, led by Baxter Ventures, with participation from CWC HealthTech Advisors, Stanford-StartX Fund, and Summation Health Ventures. The total amount raised to date is USD 7.62 mn, and the company is currently valued at USD 39.11 mn. Insoo Suh is the founder of the company.Prescient Surgical offers a suite of innovative products specifically designed to tackle challenges in the surgical field. Their core offerings include technologies that enhance operational efficiency and patient safety within operating rooms. The company targets both B2B and B2C markets, providing tools that facilitate seamless interactions and improve service delivery for healthcare providers. The primary customer segments encompass hospitals and surgical centers globally, including markets in North America, Europe, and Asia.The company's revenue model is structured around direct sales and subscriptions for their flagship products. Clients engage in annual or monthly subscription plans, providing them access to the entire suite of services. Moreover, partnerships with healthcare facilities and distributors enhance the company's market reach and revenue flow, driven by a growing client base that relies on their innovative surgical technologies.In conjunction with the recent Series B funding raised in October 2018, Prescient Surgical plans to invest in the development of new surgical technologies aimed at further enhancing patient outcomes. The company intends to expand its reach into European and Asian markets by 2021, capitalizing on the growing demand for advanced surgical solutions. The funding will be utilized to support these product developments and market expansions, ensuring comprehensive coverage and support for diverse healthcare needs.

## Funding rounds

- Series B, Oct 26, 2018, $7.6M — CWC HealthTech Advisors, Baxter Ventures, Summation Health Ventures, Stanford-StartX Fund
- Series A, Oct 28, 2014, $2.1M — Summation Health Ventures
- Series A, Sep 22, 2014, $3.9M — Summation Health Ventures

## Investors

- Summation Health Ventures (https://capitalatlas.ai/funds/summation-health-ventures) — Series A, Series B
- CWC HealthTech Advisors (https://capitalatlas.ai/funds/cwc-healthtech-advisors) — Series B
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series B
- Stanford-StartX Fund — Series B